The Chromosome XON Microarray High Resolution Test is an advanced genetic test offered by DNA Labs UAE, designed to provide comprehensive insights into the X chromosome's structure and function. This high-resolution microarray analysis allows for the detection of various genetic abnormalities, including deletions, duplications, and other alterations that could be linked to a range of genetic disorders and conditions. With a focus on the X chromosome, this test is particularly relevant for diagnosing conditions that have a sex-linked pattern of inheritance.
Priced at 6440 AED, the test represents a significant investment in personal health and genetic understanding. It is conducted using cutting-edge technology to ensure accurate and detailed results, providing patients and healthcare providers with crucial information that can guide medical management, treatment decisions, and genetic counseling. DNA Labs UAE, a leading facility in the field of genetic testing, offers this test as part of its commitment to providing advanced diagnostic solutions to its clients. The test is suitable for individuals seeking detailed insights into their genetic makeup, especially in cases where there is a suspected genetic condition or a family history of X-linked disorders.
The NIPT (Non-Invasive Prenatal Testing) Microdeletion Test is a cutting-edge prenatal screening test offered by DNA Labs UAE. This test is designed to detect microdeletions, which are small missing pieces of DNA, in the fetus's genome that could lead to genetic disorders. Unlike traditional prenatal tests, the NIPT Microdeletion Test is non-invasive, requiring only a blood sample from the expectant mother, making it a safer option for both mother and child.
Priced at 2400 AED, the test provides expectant parents with crucial early information about potential genetic conditions that could affect their baby's health. Conducted with high precision and accuracy, this screening can detect conditions such as DiGeorge syndrome, Prader-Willi syndrome, and Angelman syndrome, among others. DNA Labs UAE, known for its state-of-the-art facilities and expert team, ensures a reliable testing process, offering peace of mind to parents during the critical phases of pregnancy.
Whole Exome Sequencing (WES) Test is an advanced genetic screening method offered by DNA Labs UAE, aimed at providing comprehensive insights into an individual's genetic makeup. This test specifically focuses on the exome, which constitutes approximately 1% of the genome but contains the majority of known genetic variants associated with diseases. By examining the coding regions of genes where most genetic mutations occur, WES is highly effective in identifying genetic disorders, understanding rare diseases, and informing personalized medicine approaches.
The WES Test at DNA Labs UAE is priced at 5200 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then subjected to high-throughput sequencing to analyze the exome's vast array of genetic information. This process enables the identification of both common and rare genetic variations that could be crucial in diagnosing genetic conditions, predicting disease risks, and tailoring medical treatments to the individual's genetic profile.
DNA Labs UAE provides this service with a commitment to accuracy, confidentiality, and support through genetic counseling to help individuals understand their test results. The WES Test is a powerful tool in the field of genetic testing, offering insights that can significantly impact healthcare decisions and outcomes.
Microarray 60K AFCVS, along with Karyotyping and FISH (Fluorescence In Situ Hybridization) for Chromosome 21, are advanced genetic tests designed to detect chromosomal abnormalities and genetic disorders. These tests are particularly crucial in prenatal diagnostics, cancer research, and for understanding genetic diseases.
The Microarray 60K AFCVS (Array-based Comparative Genomic Hybridization) is a comprehensive test that scans the entire genome for gains and losses of genetic material, providing detailed insights into numerous genetic conditions. It is capable of detecting abnormalities that are often missed by traditional cytogenetic techniques.
Karyotyping is a test that gives a complete picture of an individual's chromosomes. It is used to look for abnormal numbers or structures of chromosomes, which can lead to genetic diseases. It's particularly useful for diagnosing conditions like Down syndrome, where an extra copy of chromosome 21 is present.
FISH for Chromosome 21 is a more targeted approach, specifically designed to detect abnormalities in chromosome 21, including microdeletions or duplications that could lead to genetic disorders such as Down syndrome. This technique uses fluorescent probes that bind to specific parts of the chromosome, making it easier to visualize and analyze these regions under a microscope.
Offered at DNA Labs UAE, the combined test cost for these advanced genetic testing techniques is 5200 AED. This comprehensive suite of tests provides invaluable insights for individuals seeking detailed information about their genetic health, potential genetic disorders, or the genetic health of their unborn child. DNA Labs UAE is equipped with state-of-the-art technology and staffed by expert professionals to ensure accurate and reliable test results.
The Very Long Chain Fatty Acids (VLCFA) test is a specialized diagnostic examination aimed at measuring the levels of specific fatty acids in the body, which are crucial for various cellular functions, including energy production and the maintenance of cell membranes. This test is particularly significant in the detection and management of certain genetic metabolic disorders, such as X-linked adrenoleukodystrophy (X-ALD), which affects the nervous system and adrenal glands.
Performed at DNA Labs UAE, a leading facility renowned for its advanced diagnostic services, the VLCFA test is conducted through a blood sample. The process involves sophisticated laboratory techniques to accurately quantify the concentrations of very long chain fatty acids, providing essential insights into the metabolic functions of the patient.
The cost of the VLCFA test at DNA Labs UAE is set at 5100 AED. While the price might seem steep, the value of this test lies in its ability to offer critical data that can guide therapeutic strategies, potentially improving the quality of life for individuals with metabolic disorders. Patients considering this test are encouraged to consult with their healthcare provider to understand its relevance and implications fully.
The Von Willebrand Disease (VWD) Panel Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect and categorize Von Willebrand Disease, a genetic disorder that affects blood clotting. Priced at 6080 AED, this test is crucial for individuals who exhibit symptoms of bleeding disorders or have a family history of VWD. It analyzes various factors including the levels of von Willebrand factor (VWF) and its functionality, which are essential for the proper clotting of blood. By conducting this panel test, healthcare providers can determine the specific type of VWD affecting the patient—ranging from Type 1, the most common and mildest form, to Type 3, the most severe form of the disease. This information is vital for developing an effective treatment plan and managing the condition effectively. DNA Labs UAE employs state-of-the-art technology and follows strict protocols to ensure accurate and reliable test results, making it a trusted choice for patients and healthcare professionals alike.
The Liquid Biopsy 56 Gene Panel Test, offered by DNA Labs UAE, represents a cutting-edge advancement in the field of non-invasive cancer diagnostics. Priced at 6000 AED, this innovative test utilizes a simple blood sample to analyze circulating tumor DNA (ctDNA) for mutations across 56 genes known to be associated with various cancers. This broad-spectrum approach enables healthcare providers to identify genetic mutations that could influence a patient's cancer treatment and management plan without the need for more invasive biopsy procedures. The convenience of a blood draw, combined with the comprehensive nature of the gene panel, makes this test a valuable tool in personalized cancer care, aiding in early detection, monitoring of treatment response, and detection of potential relapses. DNA Labs UAE, by offering this advanced diagnostic solution, plays a pivotal role in enhancing cancer care through precision medicine.
The "Lung Cancer Panel 3 EGFR/ALK1/ROS1/MET Test" is a comprehensive molecular diagnostic test offered by DNA Labs UAE, designed to identify specific genetic mutations associated with lung cancer. This panel focuses on four key genes: EGFR, ALK1, ROS1, and MET, which are known to play significant roles in the development and progression of lung cancer. By analyzing these genes, the test can help determine the most effective treatment options for patients, including targeted therapies that can significantly improve outcomes.
The cost of the Lung Cancer Panel 3 test is 6600 AED. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test involves a detailed examination of the patient's DNA sample to identify mutations in the specified genes. This information is crucial for oncologists to tailor treatment plans to the genetic profile of the tumor, thereby offering a personalized approach to lung cancer treatment. The results from this test can provide valuable insights into the prognosis of the disease and guide decisions regarding the use of specific drugs or treatment regimens, making it a vital tool in the management of lung cancer.
The "Lung Cancer Panel 4 EGFRALK1ROS1METPD L1 Test" is a comprehensive genomic profiling assay performed at DNA Labs UAE, designed to identify specific genetic mutations and alterations in lung cancer patients. This panel targets key genes associated with lung cancer, including EGFR, ALK1, ROS1, MET, and PD-L1, which are crucial for personalized medicine and targeted therapy decisions. By analyzing these genes, oncologists can tailor treatment strategies to the individual's genetic makeup, improving outcomes and minimizing unnecessary treatments. The test cost is 6000 AED, reflecting the sophisticated technology and expertise required to accurately identify these mutations. Conducted at DNA Labs UAE, a facility known for its advanced diagnostic capabilities and commitment to precision medicine, this test represents a significant step forward in the management and treatment of lung cancer, offering hope for more effective and personalized care.
The "Lung Cancer Panel 6 EGFR by Sequencing, ALK by IHC, ROS1 by FISH Test" is a comprehensive diagnostic panel offered by DNA Labs UAE, designed to detect specific genetic mutations and alterations in lung cancer patients. This panel includes three critical tests: EGFR mutation analysis by sequencing, ALK rearrangements by Immunohistochemistry (IHC), and ROS1 rearrangements by Fluorescence in situ hybridization (FISH).
1. **EGFR by Sequencing**: This part of the panel identifies mutations in the EGFR gene, which can influence the growth and spread of cancer cells. Sequencing the EGFR gene helps in determining the eligibility of patients for targeted therapy using EGFR inhibitors.
2. **ALK by IHC**: ALK testing by IHC (Immunohistochemistry) is used to detect rearrangements in the ALK gene. These rearrangements can lead to abnormal cell growth and cancer. Identifying ALK rearrangements is crucial for selecting patients who may benefit from ALK inhibitors, a targeted cancer therapy.
3. **ROS1 by FISH**: The ROS1 portion utilizes Fluorescence in situ hybridization (FISH) to identify rearrangements in the ROS1 gene. Similar to ALK, ROS1 rearrangements are actionable targets in lung cancer treatment, with specific inhibitors available for patients with these genetic alterations.
Priced at 6000 AED, this panel is a valuable tool for the personalized management of lung cancer, enabling healthcare providers to tailor treatment strategies based on the genetic profile of a patient's tumor. Conducted at DNA Labs UAE, a facility known for its cutting-edge technology and expertise in genetic testing, this panel ensures accurate and reliable results, guiding the course of treatment for lung cancer patients towards more effective and targeted therapies.
